Improved Pharma continued collaboration with expert colleagues in the field of amorphous studies has resulted in a new publication. The article can be downloaded...
ABCT, the Accelerator for Biosciences in Connecticut, announced the second cohort of emerging biosciences ventures invited to participate in the annual program. Nine ventures...
Antengene Corporation Limited, a leading innovative, global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer and other life-threatening...
Envista Holdings Corporation announced that the U.S. Food and Drug Administration (FDA) has cleared the Nobel Biocare N1™ implant system. Boasting a biologically driven...
WuXi Biologics, a global company with leading open-access biologics technology platforms, and ImmuneOncia Therapeutics, Inc., a clinical-stage, immuno-oncology company in South Korea, announced that...
